[1]吴阶平.吴阶平泌尿外科学(上册)[M ].济南:山东科技出版社,2004:4478.
[2]Wen CHENG,Zhifeng WEI,Jianping GAO,et al.Effects of combined siRNA-TR and –TERT on telomerase activity and growth of bladder transitional cell cancer BIU-87 cells[J].Huazhong Univ Sci Technol[Med Sci],2010,30(3):391-396.
[3]Shell S,Park SM,Radjabi AR,et al.Let-7 expression defines two differentiation stages of cancer[J].Proc Natl Acad Sci USA,2007,104(27):11400-11405.
[4]Castanotto D,Rossi JJ.The promises and pitfalls of RNA-interferencebased therapeutics[J].Nature,2009,457(7228):426-433.
[5]王小红,王军青,王志君,等.HLA-G在子痫前期患者与正常妊娠胎盘中的差异表达[J].东南国防医药,2010,12(1):18-20.
[6]徐 锋,高建平,程 文.MicroRNA和肿瘤[J].东南国防医药,2008,10(6):436-438.
[7]程 文,高建平,张征宇,等.Ⅱ级膀胱尿路上皮癌microRNA差异表达及意义[J].医学研究生学报,2010,23(1):48-52.
[8]Gu S,Jin L,Zhang F,et al.Biological basis for restriction of microRNA targets to the 3 ' untranslated region in mammalian mRNAs[J].Nat Struct Mol Biol,2009,16(2):144-150.
[9]Garzon R,Fabbri M,Cimmino A,et al.MicroRNA expression and function in cancer[J].TrendsMol Med,2006,12(12):580-587.
[10] Veerla S,Lindgren D,Kvist A,et al.miRNA expression in urothelial carcinomas:important roles of miR-10a,miR-222,miR-125b,miR-7 and miR-452 for tumor stage and metastasis,and frequent homozygous losses of miR-31[J].Int J Cancer,2009,124(9):2236-2242.
[11] Saito Y,Liang G,Egger G,et al.Specific activation of microRNA-127 with downregulation of the proto-oncogene BCL6 by chromatin-modifying drugs in human cancer cells[J].Cancer Cell,2006,9(6):435-443.
[12] Song T,Zhang X,Wang C,et al.Expression of miR-143 reduces growth and migration of human bladder carcinoma cells by targeting cyclooxygenase-2[J].Br J Cancer,2010,102(5):883-891.